Skip to Content

Lazard International Strategic Eq Open LISOX

Medalist Rating as of | See Lazard Investment Hub
  • NAV / 1-Day Return 16.01  /  +0.88 %
  • Total Assets 3.9 Bil
  • Adj. Expense Ratio
    1.070%
  • Expense Ratio 1.070%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.18%
  • Turnover 43%

USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 10:17 PM GMT+0

Morningstar’s Analysis LISOX

Will LISOX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Has the elements to succeed.

Senior Analyst Chris Tate

Chris Tate

Senior Analyst

Summary

Lazard International Strategic Equity has the ingredients to succeed but needs to deliver on its advantages.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LISOX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 30.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

4.82 198.2 Mil
Healthcare

RELX PLC

4.05 166.4 Mil
Industrials

ASML Holding NV

3.42 140.4 Mil
Technology

Icon PLC

2.94 120.9 Mil
Healthcare

State Street Instl Treasury MMkt Instl

2.76 113.4 Mil
Cash and Equivalents

Airbus SE

2.76 113.3 Mil
Industrials

Aon PLC Class A

2.62 107.5 Mil
Financial Services

Taiwan Semiconductor Manufacturing Co Ltd

2.50 102.7 Mil
Technology

Siemens AG

2.45 100.7 Mil
Industrials

Ryanair Holdings PLC ADR

2.36 97.0 Mil
Industrials